Good afternoon :)
Place Order
Add to Watchlist

Sanjivani Paranteral Ltd

SANJIVIN Share Price

211.203.23% (-7.05)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹266 cr, stock is ranked 2,273

Stock is 3.29x as volatile as Nifty

SANJIVIN Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹266 cr, stock is ranked 2,273

Stock is 3.29x as volatile as Nifty

SANJIVIN Performance & Key Metrics

SANJIVIN Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.889.550.22%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.596.400.79%

SANJIVIN Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

SANJIVIN Company Profile

Sanjivani Paranteral is engaged in the business of pharmaceutical products.

SANJIVIN Similar Stocks (Peers)

Compare with peers Compare with peers 

SANJIVIN Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.50
36.50
1Y Return
4.00%
4.00%
Buy Reco %
87.10
87.10
PE Ratio
22.64
22.64
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
PE Ratio
59.13
59.13
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
PE Ratio
18.58
18.58
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
PE Ratio
52.73
52.73
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
Compare with Peers

SANJIVIN Sentiment Analysis

SANJIVIN Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

SANJIVIN Stock Summary · May 2025

Sanjivani Parenteral Limited demonstrated robust financial performance in Q4 and FY '25, with a remarkable 41.3% year-on-year revenue growth, driven by new product launches and strategic market expansions, particularly in French-speaking African nations and Central and Latin America. The company is enhancing its operational readiness through joint ventures, notably in Prague, which positions it favorably in the European nutraceutical market. Despite challenges such as increased employee costs and initial production ramp-up at new facilities, management remains optimistic about future growth, supported by stable raw material prices and a focus on local manufacturing. The commitment to operational efficiency and a diverse product portfolio is expected to sustain momentum as the company navigates new market entries and regulatory landscapes.

SANJIVIN Stock Growth Drivers
SANJIVIN Stock Growth Drivers
7
  • Strong Financial Performance

    Sanjivani Parenteral Limited reported significant revenue growth, achieving a 41.3% year-on-year increase in Q4 FY

  • Expansion of Product Portfolio

    The company successfully expanded its product portfolio to 160 products by launching 15 new products

SANJIVIN Stock Challenges
SANJIVIN Stock Challenges
0
No ConsHmm, looks like there are no
challenges

SANJIVIN Forecast

SANJIVIN Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

SANJIVIN

SANJIVIN

Income

Balance Sheet

Cash Flow

SANJIVIN Income Statement

SANJIVIN Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 33.83%, vs industry avg of 10.1%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.01% to 0.02%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue35.5218.4526.0516.6125.3630.8542.0259.4771.3171.31
Raw Materialssubtract28.6724.9414.609.9314.1412.6619.8434.3759.7559.75
Power & Fuel Costsubtract0.961.080.730.580.780.981.101.14
Employee Costsubtract2.772.962.372.252.132.732.913.74
Selling & Administrative Expensessubtract5.093.112.762.602.917.225.329.45
Operating & Other expensessubtract18.4538.096.391.333.011.306.662.01
Depreciation/Amortizationsubtract1.201.191.171.070.860.880.890.930.620.62
Interest & Other Itemssubtract4.790.450.330.660.130.210.360.250.590.59
Taxes & Other Itemssubtract-0.19-0.32-0.23-0.10-0.010.030.431.412.262.25
EPS-44.45-89.94-3.51-2.901.965.234.515.696.896.93
DPS0.000.000.000.000.000.000.000.000.500.00
Payout ratio0.000.000.000.000.000.000.000.000.070.00

SANJIVIN Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

SANJIVIN Stock Peers

SANJIVIN Past Performance & Peer Comparison

SANJIVIN Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sanjivani Paranteral Ltd32.929.550.22%
Sun Pharmaceutical Industries Ltd36.505.500.96%
Cipla Ltd22.643.821.08%
Torrent Pharmaceuticals Ltd59.1314.890.18%

SANJIVIN Stock Price Comparison

Compare SANJIVIN with any stock or ETF
Compare SANJIVIN with any stock or ETF
SANJIVIN
Loading...

SANJIVIN Holdings

SANJIVIN Shareholdings

SANJIVIN Promoter Holdings Trend

SANJIVIN Promoter Holdings Trend

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.20%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

SANJIVIN Institutional Holdings Trend

SANJIVIN Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

SANJIVIN Shareholding Pattern

SANJIVIN Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding28.87%0.00%6.15%0.00%64.98%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

SANJIVIN Shareholding History

SANJIVIN Shareholding History

FebMarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

SANJIVIN Insider Trades & Bulk Stock Deals

SANJIVIN Insider Trades & Bulk Stock Deals

Loading...

smallcases containing SANJIVIN stock

smallcases containing SANJIVIN stock

Looks like this stock is not in any smallcase yet.

SANJIVIN Events

SANJIVIN Events

SANJIVIN Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

SANJIVIN Dividend Trend

No dividend trend available

SANJIVIN Dividends

SANJIVIN Dividends

Hmm, looks like data is unavailable here. Please come back after some time

SANJIVIN Stock News & Opinions

SANJIVIN Stock News & Opinions

Earnings
Sanjivani Paranteral consolidated net profit rises 73.81% in the March 2025 quarter

Net profit of Sanjivani Paranteral rose 73.81% to Rs 2.19 crore in the quarter ended March 2025 as against Rs 1.26 crore during the previous quarter ended March 2024. Sales rose 41.37% to Rs 18.18 crore in the quarter ended March 2025 as against Rs 12.86 crore during the previous quarter ended March 2024. For the full year,net profit rose 31.12% to Rs 8.09 crore in the year ended March 2025 as against Rs 6.17 crore during the previous year ended March 2024. Sales rose 28.84% to Rs 70.10 crore in the year ended March 2025 as against Rs 54.41 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales18.1812.86 41 70.1054.41 29 OPM %14.3616.80 -14.7615.14 - PBDT2.842.12 34 10.978.50 29 PBT2.651.88 41 10.357.57 37 NP2.191.26 74 8.096.17 31 Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Sanjivani Paranteral standalone net profit rises 73.81% in the March 2025 quarter

Net profit of Sanjivani Paranteral rose 73.81% to Rs 2.19 crore in the quarter ended March 2025 as against Rs 1.26 crore during the previous quarter ended March 2024. Sales rose 41.37% to Rs 18.18 crore in the quarter ended March 2025 as against Rs 12.86 crore during the previous quarter ended March 2024. For the full year,net profit rose 31.28% to Rs 8.10 crore in the year ended March 2025 as against Rs 6.17 crore during the previous year ended March 2024. Sales rose 28.84% to Rs 70.10 crore in the year ended March 2025 as against Rs 54.41 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales18.1812.86 41 70.1054.41 29 OPM %14.3016.87 -14.7815.14 - PBDT2.832.13 33 10.988.51 29 PBT2.651.89 40 10.367.58 37 NP2.191.26 74 8.106.17 31 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Sanjivani Paranteral recommends final dividend

Sanjivani Paranteral announced that the Board of Directors of the Company at its meeting held on 27 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Sanjivani Paranteral to discuss results

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Sanjivani Paranteral standalone net profit rises 15.15% in the December 2024 quarter

Net profit of Sanjivani Paranteral rose 15.15% to Rs 1.90 crore in the quarter ended December 2024 as against Rs 1.65 crore during the previous quarter ended December 2023. Sales rose 15.98% to Rs 17.35 crore in the quarter ended December 2024 as against Rs 14.96 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales17.3514.96 16 OPM %14.7013.17 - PBDT2.672.14 25 PBT2.511.90 32 NP1.901.65 15 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Sanjivani Paranteral to discuss results

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Sanjivani Paranteral standalone net profit rises 34.50% in the September 2024 quarter

Net profit of Sanjivani Paranteral rose 34.50% to Rs 2.30 crore in the quarter ended September 2024 as against Rs 1.71 crore during the previous quarter ended September 2023. Sales rose 29.50% to Rs 18.13 crore in the quarter ended September 2024 as against Rs 14.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales18.1314.00 30 OPM %15.7715.14 - PBDT3.072.22 38 PBT2.921.99 47 NP2.301.71 35 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 9 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Sanjivani Paranteral AGM scheduled

Sanjivani Paranteral announced that the 30th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Sanjivani Paranteral Ltd (SANJIVIN) today?

    The share price of SANJIVIN as on 11th July 2025 is ₹211.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Sanjivani Paranteral Ltd (SANJIVIN) share?

    The past returns of Sanjivani Paranteral Ltd (SANJIVIN) share are
    • Past 1 week: -0.32%
    • Past 1 month: -10.20%
    • Past 3 months: -2.17%
    • Past 6 months: -36.71%
    • Past 1 year: 5.46%
    • Past 3 years: 347.23%
    • Past 5 years: 2452.63%

  3. What are the peers or stocks similar to Sanjivani Paranteral Ltd (SANJIVIN)?
  4. What is the dividend yield % of Sanjivani Paranteral Ltd (SANJIVIN) share?

    The current dividend yield of Sanjivani Paranteral Ltd (SANJIVIN) is 0.22.

  5. What is the market cap of Sanjivani Paranteral Ltd (SANJIVIN) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanjivani Paranteral Ltd (SANJIVIN) is ₹266.36 Cr as of 11th July 2025.

  6. What is the 52 week high and low of Sanjivani Paranteral Ltd (SANJIVIN) share?

    The 52-week high of Sanjivani Paranteral Ltd (SANJIVIN) is ₹396.95 and the 52-week low is ₹190.

  7. What is the PE and PB ratio of Sanjivani Paranteral Ltd (SANJIVIN) stock?

    The P/E (price-to-earnings) ratio of Sanjivani Paranteral Ltd (SANJIVIN) is 32.92. The P/B (price-to-book) ratio is 9.55.

  8. Which sector does Sanjivani Paranteral Ltd (SANJIVIN) belong to?

    Sanjivani Paranteral Ltd (SANJIVIN) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Sanjivani Paranteral Ltd (SANJIVIN) shares?

    You can directly buy Sanjivani Paranteral Ltd (SANJIVIN) shares on Tickertape. Simply sign up, connect your demat account and place your order.